V. Ninane (Brussels, Belgium), C. Brambilla (Grenoble, France)
Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients? C. Heigl, F. von Bueltzingsloewen, G. Siemon (Donaustauf, Germany)
| |
Detection of bronchial preneoplastic lesions and early cancers in high-risk patients: a comparison of LIFE and Pentax autofluorescence bronchoscopy J. Faber, P. Pierard, B. Martin, J. M. Verdebout, M. Richez, S. Bensliman, J. P. Sculier, V. Ninane (Brussels, Belgium)
| |
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways G. J. M. Herder, E. F. I. Comans, P. E. Postmus, T. G. Sutedja (Amsterdam, The Netherlands)
| |
Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma A. Gröschel, D. Hellwig, K. Rentz, C. M. Kirsch, D. Ukena, G. W. Sybrecht (Homburg, Germany)
| |
Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) S. M. Lang, D. F. Stratakis, J. Benedikter, S. Gallenberger, M. Maehle, R. M. Huber (Munich, Germany)
| |
The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions B. Martin, J. M. Verdebout, C. Mascaux, M. Paesmans, G. Rouas, A. Verhest, V. Ninane, J. P. Sculier (Brussels, Belgium)
| |
Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential E. A. Kogan, N. B. Paramonova, V. P. Seredin (Moscow, Russia)
| |
Inhalation of vitamin A: reversibility of bronchial squamous metaplasia and dysplasia M. Kohlhäufl, K. Häussinger, F. Stanzel, B. Jany, I. C. Golly, G. Scheuch, A. Morresi-Hauf, H. K. Biesalski (Munich, Würzburg, Hohenheim, Germany)
| |